利用机器学习刻画阳性淋巴结数目对子宫内膜癌的影响:比FIGO分期更好的预后指标?
基于美国国家癌症数据库的11,381例无远处转移的淋巴结阳性子宫内膜腺癌患者,训练机器学习模型并用SHAP值确定阳性淋巴结数目分界为1-3枚、4-5枚和6枚及以上。3年总生存率分别为82.0%、74.3%(HR 1.38;p<0.001)和59.9%(HR 2.23;p<0.001)。结论认为阳性淋巴结数目是比PA淋巴结受累更强的预后和预测因素。
要点
- 阳性淋巴结数目分界为1-3枚、4-5枚和6枚及以上,3年OS分别为82.0%、74.3%和59.9%。
- 与1-3枚组相比,4-5枚组HR 1.38(p<0.001),6枚及以上组HR 2.23(p<0.001)。
- PA淋巴结受累单因素分析显著(HR 1.20;p<0.001),纳入淋巴结数目后多因素分析不显著(HR 1.05;p=0.273)。
核心结论
- 阳性淋巴结数目是比PA淋巴结受累更强的预后和预测因素。
研究设计与样本
- 在美国国家癌症数据库中识别无远处转移的淋巴结阳性子宫内膜腺癌患者,共11,381例。
- 训练基于总生存的机器学习模型,使用SHAP值确定阳性淋巴结数目的分界,并用Cox比例风险回归模型验证结果。
主要发现
- SHAP值选定的阳性淋巴结数目分界为1-3枚、4-5枚和6枚及以上。
- 3年OS:1-3枚组82.0%,4-5枚组74.3%(HR 1.38;p<0.001),6枚及以上组59.9%(HR 2.23;p<0.001)。
- 单因素Cox回归中PA淋巴结受累是OS的显著预测因素(HR 1.20;p<0.001),纳入淋巴结数目后多因素分析不显著(HR 1.05;p=0.273)。
- 辅助治疗与阳性淋巴结数目存在交互作用。
- 1-3枚阳性淋巴结组接受放化疗、化疗和放疗的3年OS分别为85.2%、78.7%和74.2%。
关键数值与推荐
- 阳性淋巴结数目分界:1-3枚、4-5枚、6枚及以上。
- 3年OS:1-3枚组82.0%,4-5枚组74.3%(HR 1.38;p<0.001),6枚及以上组59.9%(HR 2.23;p<0.001)。
- PA淋巴结受累单因素HR 1.20(p<0.001),多因素HR 1.05(p=0.273)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Number of involved lymph nodes (LNs) is a crucial stratification factor in staging of numerous disease sites, but has not been incorporated for endometrial cancer. We evaluated whether number of involved LNs provide improved prognostic value. PATIENTS AND METHODS: Patients diagnosed with node-positive endometrial adenocarcinoma without distant metastasis were identified in the National Cancer Database. We trained a machine-learning based model of overall survival. Shapley additive explanation values (SHAP) based on the model were used to identify cutoffs of number of LNs involved. Results were validated using a Cox proportional hazards regression model. RESULTS: We identified 11,381 patients with endometrial cancer meeting the inclusion criteria. Using the SHAP values, we selected the following thresholds: 1-3 LNs, 4-5 LNs, and 6+ LNs. The 3-year OS was 82.0% for 1-3 LNs, 74.3% for 4-5 LNs (hazard ratio [HR] 1.38; p < 0.001), and 59.9% for 6+ LNs (HR 2.23; p < 0.001). On univariate Cox regression, PA nodal involvement was a significant predictor of OS (HR 1.20; p < 0.001) but was not significant on multivariate analysis when number of LNs was included (HR 1.05; p = 0.273). Additionally, we identified an interaction between adjuvant therapy and number of involved LNs. Patients with 1-3 involved LNs had 3-year OS of 85.2%, 78.7% and 74.2% with chemoradiation (CRT), chemotherapy, and radiation, respectively. Patients with 6+ involved LNs had 3-yr OS of 67.8%, 49.6%, and 48.9% with CRT, chemotherapy, and radiation, respectively (p < 0.001). CONCLUSION: Number of involved LNs is a stronger prognostic and predictive factor compared to PA node involvement.
引用
- Ladbury C, Li R, Shiao J, et al. Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging? Gynecol Oncol. 2021. PMID: 34794840. doi:10.1016/j.ygyno.2021.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。